Trademark: 88583412
Word
CYTEGRITY
Status
Dead
Status Code
606
Status Date
Monday, April 8, 2024
Serial Number
88583412
Mark Type
4000
Filing Date
Monday, August 19, 2019
Published for Opposition
Tuesday, January 5, 2021
Abandoned Date
Monday, April 8, 2024

Trademark Owner History
CSL BEHRING GENE THERAPY, INC. - 1st New Owner After Publication
Calimmune, Inc. - Owner At Publication

Classifications
5 Cell lines for medical purposes; Cells for medical or clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating cancer, tumors, genetic diseases, immunodeficiency conditions, stem cell transplantation, and transplant medicine; Cell lines for medical purposes, namely, cell therapy; Cell lines for medical purposes, namely, immunotherapy; Cell lines for medical purposes, namely, for use as therapeutics to repair, replace or preserve cells and tissues; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating genetically engineered tissues and for treating transplant conditions; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating viral and infectious diseases; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders
1 Cell lines for scientific and research use; Cells for scientific, laboratory or medical research; Biological preparations, namely, viral vectors and gene vectors for scientific, laboratory or medical research

Trademark Events
Apr 8, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 8, 2024
Abandonment - No Use Statement Filed
Aug 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 8, 2023
Sou Extension 5 Granted
Aug 1, 2023
Sou Extension 5 Filed
Aug 8, 2023
Case Assigned To Intent To Use Paralegal
Aug 1, 2023
Sou Teas Extension Received
Feb 4, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 2, 2023
Sou Extension 4 Granted
Feb 2, 2023
Sou Extension 4 Filed
Feb 2, 2023
Sou Teas Extension Received
Jan 4, 2023
Automatic Update Of Assignment Of Ownership
Aug 4, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 2, 2022
Sou Extension 3 Granted
Aug 2, 2022
Sou Extension 3 Filed
Aug 2, 2022
Sou Teas Extension Received
Feb 4, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 2, 2022
Sou Extension 2 Granted
Feb 2, 2022
Sou Extension 2 Filed
Feb 2, 2022
Sou Teas Extension Received
Jul 30, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 28, 2021
Sou Extension 1 Granted
Jul 28, 2021
Sou Extension 1 Filed
Jul 28, 2021
Sou Teas Extension Received
Mar 2, 2021
Noa E-Mailed - Sou Required From Applicant
Jan 5, 2021
Official Gazette Publication Confirmation E-Mailed
Jan 5, 2021
Published For Opposition
Dec 16, 2020
Notification Of Notice Of Publication E-Mailed
Dec 1, 2020
Approved For Pub - Principal Register
Nov 13, 2020
Teas/Email Correspondence Entered
Nov 13, 2020
Correspondence Received In Law Office
Nov 2, 2020
Teas Request For Reconsideration Received
Jun 23, 2020
Notification Of Final Refusal Emailed
Jun 23, 2020
Final Refusal E-Mailed
Jun 23, 2020
Final Refusal Written
Jun 5, 2020
Teas/Email Correspondence Entered
Jun 5, 2020
Correspondence Received In Law Office
Jun 3, 2020
Assigned To Lie
May 26, 2020
Teas Response To Office Action Received
Nov 26, 2019
Notification Of Non-Final Action E-Mailed
Nov 26, 2019
Non-Final Action E-Mailed
Nov 26, 2019
Non-Final Action Written
Nov 19, 2019
Assigned To Examiner
Sep 4, 2019
New Application Office Supplied Data Entered
Aug 22, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24